Edwards Lifesciences Shareholders Equity Trend

EW -- USA Stock  

USD 139.39  0.38  0.27%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Shareholders Equity of Edwards Lifesciences Corporation with missing and latest data points interpolated. A principal component of the balance sheet; in addition to Total Liabilities and Total Assets; that represents the total of all stockholders' equity (deficit) items; net of receivables from officers; directors; owners; and affiliates of the entity which are attributable to the parent.
Shareholders Equity10 Years Trend
Increasing
Slightly volatile
 Shareholders Equity 
      Timeline 

Regression Statistics

Arithmetic Mean  1,732,795,175
Geometric Mean  1,547,975,501
Coefficient Of Variation  44.09
Mean Deviation  660,727,705
Median  1,544,400,000
Standard Deviation  764,018,790
Range  2,237,142,105
R Value  0.98
R Squared  0.95
Significance  0.00000007
Slope  206,636,934

Edwards Lifesciences Shareholders Equity Over Time

2016-12-31  2,619,000,000 
2017-12-31  2,619,000,000 
2018-12-31  2,695,842,105 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

Edwards Lifesciences Upcoming Company Events
Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.